Van Hecken A - Search Results

1

Comparative oral pharmacokinetics of fleroxacin and pefloxacin.

De Lepeleire I, Van Hecken A, Verbesselt R, Tjandra-Maga TB, De Schepper PJ. De Lepeleire I, et al. Among authors: van hecken a. J Antimicrob Chemother. 1988 Aug;22(2):197-202. doi: 10.1093/jac/22.2.197. J Antimicrob Chemother. 1988. PMID: 3141343 Clinical Trial.

2

Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers.

Van Hecken AM, Depré M, De Schepper PJ, Fowler PA, Lacey LF, Durham JM. Van Hecken AM, et al. Br J Clin Pharmacol. 1992 Jul;34(1):82-4. doi: 10.1111/j.1365-2125.1992.tb04113.x. Br J Clin Pharmacol. 1992. PMID: 1321655 Free PMC article. Clinical Trial.

3

Pharmacodynamics and tolerability of L-654,066, a steroid 5 alpha-reductase inhibitor, in men.

Depré M, Meeter C, Van Hecken A, Laskin OL, Buntinx A, De Schepper PJ. Depré M, et al. Among authors: van hecken a. Clin Pharmacol Ther. 1992 Oct;52(4):409-12. doi: 10.1038/clpt.1992.163. Clin Pharmacol Ther. 1992. PMID: 1424413 Clinical Trial.

4

Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man.

Depré M, Margolskee DJ, Hsieh JY, Van Hecken A, Buntinx A, De Lepeleire I, Rogers JD, De Schepper PJ. Depré M, et al. Among authors: van hecken a. Eur J Clin Pharmacol. 1992;43(4):427-30. doi: 10.1007/BF02220621. Eur J Clin Pharmacol. 1992. PMID: 1451725 Clinical Trial.

5

Dose-dependent kinetics of the enantiomers of MK-571, and LTD4-receptor antagonist.

Depré M, Margolskee DJ, Van Hecken A, Hsieh JS, Buntinx A, De Schepper PJ, Rogers JD. Depré M, et al. Among authors: van hecken a. Eur J Clin Pharmacol. 1992;43(4):431-3. doi: 10.1007/BF02220622. Eur J Clin Pharmacol. 1992. PMID: 1451726 Clinical Trial.

6

Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous use.

Depré M, van Hecken A, Verbesselt R, Tjandra-Maga TB, Gerin M, de Schepper PJ. Depré M, et al. Among authors: van hecken a. Fundam Clin Pharmacol. 1992;6(6):259-62. doi: 10.1111/j.1472-8206.1992.tb00119.x. Fundam Clin Pharmacol. 1992. PMID: 1487229 Clinical Trial.

7

Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5 alpha-reductase inhibitor.

De Schepper PJ, Imperato-McGinley J, Van Hecken A, De Lepeleire I, Buntinx A, Carlin J, Gressi MH, Stoner E. De Schepper PJ, et al. Among authors: van hecken a. Steroids. 1991 Sep;56(9):469-71. doi: 10.1016/0039-128x(91)90003-e. Steroids. 1991. PMID: 1666698

8

Lack of interaction between famotidine and warfarin.

De Lepeleire I, Van Hecken A, Verbesselt R, Tjandra-Maga TB, Buntinx A, Distlerath L, De Schepper PJ. De Lepeleire I, et al. Among authors: van hecken a. Int J Clin Pharmacol Res. 1990;10(3):167-71. Int J Clin Pharmacol Res. 1990. PMID: 2228341

9

Pharmacokinetic interaction between indomethacin and diflunisal.

Van Hecken A, Verbesselt R, Tjandra-Maga TB, De Schepper PJ. Van Hecken A, et al. Eur J Clin Pharmacol. 1989;36(5):507-12. doi: 10.1007/BF00558077. Eur J Clin Pharmacol. 1989. PMID: 2753070

10

Absence of a pharmacokinetic interaction between enalapril and frusemide.

Van Hecken AM, Verbesselt R, Buntinx A, Cirillo VJ, De Schepper PJ. Van Hecken AM, et al. Br J Clin Pharmacol. 1987 Jan;23(1):84-7. doi: 10.1111/j.1365-2125.1987.tb03013.x. Br J Clin Pharmacol. 1987. PMID: 3028456 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters